Advances of MR imaging in glioma: what the neurosurgeon needs to know - Report - MDSpire

Advances of MR imaging in glioma: what the neurosurgeon needs to know

  • By

  • Anna Falk Delgado

  • June 21, 2025

  • 0 min

Share

Clinical Report: Advances in MRI Techniques for Glioma Management

Overview

High-grade gliomas remain aggressive brain tumors with poor prognosis despite multimodal treatment. Advanced MRI techniques, including perfusion imaging and diffusion-weighted imaging, provide critical insights into tumor biology, aiding diagnosis, surgical planning, and treatment monitoring.

Background

High-grade gliomas (HGGs) are among the most lethal primary brain tumors, characterized by infiltrative growth and molecular heterogeneity. The 2021 WHO classification integrates molecular diagnostics with histology, refining tumor subtypes and impacting prognosis and treatment. MRI is central to glioma care, offering superior soft tissue contrast and advanced physiological imaging methods. Techniques such as perfusion MRI and diffusion-weighted imaging enhance understanding of tumor vascularity and microstructure, informing clinical decisions.

Data Highlights

Perfusion MRI TechniqueContrast AgentKey ParametersAdvantagesLimitations
Dynamic Susceptibility Contrast (DSC)Gadolinium-basedCBV, CBF, MTT, TTPHigh SNR, rapid acquisition, widely validatedSusceptible to artifacts near air-bone interfaces, affected by hemorrhage/calcification
Dynamic Contrast-Enhanced (DCE)Gadolinium-basedVp, Ktrans, VeLess sensitive to susceptibility artifacts, useful in hemorrhagic/calcified lesionsLower SNR, complex post-processing, variable protocols
Arterial Spin Labelling (ASL)None (endogenous tracer)CBF (and possible CBV)Non-invasive, no contrast needed, useful in renal impairment and pediatricsLower spatial resolution, sensitive to motion/artifacts, may underestimate slow flow

Key Findings

  • High-grade gliomas are molecularly heterogeneous, requiring integrated imaging and molecular diagnostics for accurate classification.
  • Perfusion MRI techniques (DSC, DCE, ASL) provide complementary information on tumor vascular physiology and malignancy.
  • DSC MRI is the most commonly used perfusion method but is limited by susceptibility artifacts and hemorrhagic or calcified lesions.
  • DCE MRI offers additional parameters related to vascular permeability and plasma volume, useful when DSC is limited, though it requires complex processing.
  • ASL is a valuable non-contrast alternative, especially in patients contraindicated for gadolinium, but has lower resolution and sensitivity to motion.
  • Diffusion-weighted imaging and diffusion tensor imaging contribute to understanding tumor cellularity and white matter tract integrity, aiding surgical planning.

Clinical Implications

Selection of MRI perfusion technique should be individualized based on patient factors, lesion characteristics, and clinical questions. Combining DSC and DCE can overcome individual limitations, while ASL offers a safe alternative in patients where contrast is contraindicated. Incorporation of diffusion imaging enhances surgical planning by delineating tumor infiltration and white matter tracts.

Conclusion

Advanced MRI techniques significantly enhance the characterization and management of gliomas by providing detailed physiological and molecular insights. Their integration into clinical practice supports improved diagnostic accuracy, treatment planning, and monitoring, ultimately aiming to improve patient outcomes.

References

  1. WHO Classification of CNS Tumors 2021 -- Integrated Molecular Diagnostics
  2. Dynamic Susceptibility Contrast MRI in Brain Tumors -- Clinical Applications
  3. Arterial Spin Labelling MRI -- Non-contrast Perfusion Imaging
  4. Diffusion Tensor Imaging and Fiber Tractography -- Surgical Planning

Original Source(s)

Related Content